Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease

Fig. 1

CD107a-expressing NK cells after exposure to pre-treated ucMSC. a Representative FACS plots of CD107a expression on NK cells, without ucMSC (left), with untreated ucMSC (middle), with IFN-γ-treated ucMSC (right) b Graph displaying boxplots of CD107a-expressing NK cells after exposure to the various pre-treated MSC (untreated, IFN-γ, IFN-β, TGFβ, starvation, vitamin B6, Starv + VitB6, retinoic acid and combination IFN-γ + TGFβ + RA (MC)). Results are shown as means ± SEM (n = 4). *Indicates significant difference (p < 0.05). IFN-γ interferon gamma, MC multiple cytokine cocktail, NK natural killer cells, RA retinoic acid, Starv starvation, serum deprivation, TGFβ transforming growth factor beta, ucMSC umbilical cord-derived mesenchymal stromal cells, VitB 6 vitamin B6, pyridoxal hydrochloride

Back to article page